NeuBase Therapeutics Inc (NBSE)
0.42
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
0.42
0.00 (0.00%)
After-Hours: 19:08
NeuBase Therapeutics Total Assets (Quarterly): 18.62M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 18.62M |
June 30, 2023 | 22.33M |
March 31, 2023 | 21.46M |
December 31, 2022 | 25.58M |
September 30, 2022 | 32.69M |
June 30, 2022 | 40.00M |
March 31, 2022 | 48.81M |
December 31, 2021 | 57.04M |
September 30, 2021 | 64.17M |
June 30, 2021 | 69.32M |
March 31, 2021 | 27.47M |
December 31, 2020 | 30.76M |
September 30, 2020 | 34.44M |
June 30, 2020 | 38.16M |
March 31, 2020 | 7.716M |
December 31, 2019 | 9.878M |
September 30, 2019 | 12.53M |
June 30, 2019 | 8.693M |
March 31, 2019 | 9.632M |
December 31, 2018 | 10.67M |
September 30, 2018 | 0.2496M |
June 30, 2018 | 18.07M |
March 31, 2018 | 19.39M |
December 31, 2017 | 23.43M |
September 30, 2017 | 27.93M |
Date | Value |
---|---|
June 30, 2017 | 33.72M |
March 31, 2017 | 25.67M |
December 31, 2016 | 29.73M |
September 30, 2016 | 29.44M |
June 30, 2016 | 34.31M |
March 31, 2016 | 39.09M |
December 31, 2015 | 44.15M |
September 30, 2015 | 46.37M |
June 30, 2015 | 49.34M |
March 31, 2015 | 51.44M |
December 31, 2014 | 29.38M |
September 30, 2014 | 32.03M |
June 30, 2014 | 35.55M |
March 31, 2014 | 4.242M |
December 31, 2013 | 4.589M |
September 30, 2013 | 5.744M |
June 30, 2013 | 6.862M |
March 31, 2013 | 2.597M |
December 31, 2012 | 2.924M |
September 30, 2012 | 3.517M |
June 30, 2012 | 2.597M |
March 31, 2012 | 1.927M |
December 31, 2011 | 2.074M |
September 30, 2011 | 1.413M |
June 30, 2011 | 1.652M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.716M
Minimum
Mar 2020
69.32M
Maximum
Jun 2021
31.65M
Average
29.12M
Median
Total Assets (Quarterly) Benchmarks
Ampio Pharmaceuticals Inc | 5.736M |
Stoke Therapeutics Inc | 228.34M |
ABVC BioPharma Inc | 14.49M |
MAIA Biotechnology Inc | 7.567M |
Aprea Therapeutics Inc | 22.65M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 9.485M |
Shareholders Equity (Quarterly) | 9.137M |